Results
Kilitch Drugs FY26 PAT Rises to ₹324 Crore, AGM Scheduled
Kilitch Drugs reported 4% standalone PAT growth to ₹323.99 crore and 19% consolidated revenue increase to ₹235.47 crore for FY 2025-26.
The company commissioned its new EU-GMP/USFDA compliant manufact
